| Schedule of breakdown of the stock-based compensation expense |
The following tables provide a detailed breakdown of the stock-based compensation expense (in thousands) as reported in the Condensed Consolidated Statements of Comprehensive Income (Loss): | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | | 2026 | | 2025 | | | Options | | RSU | | Total | | Options | | RSU | | Total | Cost of Sales – Agent | | $ | — | | $ | 13,842 | | $ | 13,842 | | $ | — | | $ | 12,555 | | $ | 12,555 | Marketing Expenses – Agent | | | (28) | | | 5,622 | | | 5,594 | | | 55 | | | 3,880 | | | 3,935 | Marketing Expenses – FTE | | | — | | | 42 | | | 42 | | | — | | | 43 | | | 43 | Research and Development – FTE | | | (18) | | | 430 | | | 412 | | | — | | | 339 | | | 339 | General and Administrative – FTE (a) | | | 13 | | | 29,714 | | | 29,727 | | | 178 | | | 2,862 | | | 3,040 | Total Stock-Based Compensation (b) | | $ | (33) | | $ | 49,650 | | $ | 49,617 | | $ | 233 | | $ | 19,679 | | $ | 19,912 |
| (a) | The Company recognized $26.4 million of accelerated stock-based compensation expense in connection with the completion of the Transaction. |
| (b) | A portion of the annual corporate bonus earned is to be settled in shares. These amounts are recognized as “Accrued liabilities” in the accompanying Condensed Consolidated Balance Sheets and are not included in “Additional paid-in capital” until the shares are issued. |
| | | | | | | | | | | | | | | | | | | | | Nine Months Ended September 30, | | | 2026 | | 2025 | | | Options | | RSU | | Total | | Options | | RSU | | Total | Cost of Sales – Agent | | $ | — | | $ | 37,907 | | $ | 37,907 | | $ | — | | $ | 32,757 | | $ | 32,757 | Marketing Expenses – Agent | | | 54 | | | 14,623 | | | 14,677 | | | 180 | | | 10,348 | | | 10,528 | Marketing Expenses – FTE | | | — | | | 91 | | | 91 | | | — | | | 126 | | | 126 | Research and Development – FTE | | | (18) | | | 1,178 | | | 1,160 | | | 3 | | | 941 | | | 944 | General and Administrative – FTE (a) | | | 199 | | | 34,388 | | | 34,587 | | | 640 | | | 5,419 | | | 6,059 | Total Stock-Based Compensation (b) | | $ | 235 | | $ | 88,187 | | $ | 88,422 | | $ | 823 | | $ | 49,591 | | $ | 50,414 |
| (a) | The Company recognized $26.4 million of accelerated stock-based compensation expense in connection with the completion of the Transaction. |
| (b) | A portion of the annual corporate bonus earned is to be settled in shares. These amounts are recognized as “Accrued liabilities” in the accompanying Condensed Consolidated Balance Sheets and are not included in “Additional paid-in capital” until the shares are issued. |
|
| Summary of Stock Option Activity |
The following table outlines the number of options (in thousands) and weighted-average exercise price: | | | | | | | | | | | | | | | As of September 30, | | | 2026 | | 2025 | | | Number of
Options | | Weighted-Average
Exercise Price | | Number of
Options | | Weighted-Average
Exercise Price | Outstanding at the beginning of year | | | 1,070 | | $ | 13.20 | | | 1,499 | | $ | 10.90 | Granted | | | — | | $ | — | | | 4 | | $ | 47.30 | Forfeited/expired | | | (19) | | $ | 1.33 | | | (4) | | $ | 7.60 | Exercised | | | (19) | | $ | 8.09 | | | (361) | | $ | 5.70 | Outstanding at end of period | | | 1,032 | | $ | 13.55 | | | 1,138 | | $ | 12.70 | Exercisable at end of period | | | 959 | | $ | 13.21 | | | 932 | | $ | 11.80 |
|
| Schedule of Restricted Stock Units activity |
The following table illustrates the Company’s RSU activity (in thousands of units) under its equity plans: | | | | | Restricted Share Units | Balance, December 31, 2024 | | 2,462 | Granted | | 2,002 | Vested and issued | | (1,311) | Forfeited | | (414) | Balance, December 31, 2025 | | 2,739 | Granted | | 6,594 | Vested and issued | | (2,890) | Forfeited | | (189) | Balance, September 30, 2026 | | 6,254 |
|